Ultra-processed foods (UPFs ) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number of observational studies linking high UPF consumption to cardiometabolic diseases, the American Heart Association (AHA) issued its first comprehensive statement on the matter in 2025 in the form of a Science Advisory. The tone is noteworthy: The AHA carefully evaluates the evidence, warns against overinterpretation, and deliberately refrains from making blanket recommendations. For cardiologists and primary care physicians, it is worthwhile to understand this nuanced stance—precisely because the issue is often sensationalized in public discourse.
Publikation
- Ernährung/Adipositas-Special
Related Topics
You May Also Like
- From Risk Identification to Anti-Inflammatory Intervention
Inflammation as a Treatment Goal in Its Own Right
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD
Better to listen to the pharmacist
- Focus Update 2026
Echocardiography in Cardio-Oncology
- Physical activity with IBD
Sport is not murder, but it doesn’t help either
- White and Black Skin Cancer